The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of proteases and receptors, is reduced in inflammatory metabolic disorders such as type 2 diabetes mellitus (T2DM) and atherosclerosis. We overexpressed Timp3 in mouse macrophages (MacT3) to analyze its potential antidiabetic and antiatherosclerotic effects. Transgenic mice with myeloid cells targeting overexpression of TIMP3 were generated and fed a high-fat diet for 20 weeks. Physical and metabolic phe-notypes were determined. Inflammatory markers, lipid accumula-tion, and insulin sensitivity were measured in white adipose tissue (WAT), liver, and skeletal muscle. In a model of insulin resistance, MacT3 mice were more glucose tolerant and insu...
Obesity-driven, low-grade inflammation affects systemic metabolic function and can lead to insulin r...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Objective-Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the act...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Obesity-driven, low-grade inflammation affects systemic metabolic function and can lead to insulin r...
Obesity-driven, low-grade inflammation affects systemic metabolic function and can lead to insulin r...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of ...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Objective-Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the act...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Tissue inhibitor of metalloproteinase 3 (TIMP3) is a stromal protein that inhibits the activity of v...
Obesity-driven, low-grade inflammation affects systemic metabolic function and can lead to insulin r...
Obesity-driven, low-grade inflammation affects systemic metabolic function and can lead to insulin r...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...
Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified...